John Koconis serves as Executive at Timber Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, John Koconis has executed 2 insider transactions totaling $7.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 20, 2023 involved receiving (via award) 70,385 shares valued at $0.
John Koconis currently holds 70,785 shares of Timber Pharmaceuticals, Inc. (TMBR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Koconis has been a net buyer of TMBR stock. They have purchased $7.6K and sold $0 worth of shares.
John Koconis's most recent insider trade was on Aug 20, 2023, when they sold 70,385 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.38 |
| Discretionary |